- Home
- VEON vs CNTA Comparison
VEON vs CNTA Comparison
Compare VEON & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEON
- CNTA
- Stock Information
- Founded
- VEON 1992
- CNTA 2020
- Country
- VEON Netherlands
- CNTA United Kingdom
- Employees
- VEON N/A
- CNTA N/A
- Industry
- VEON Telecommunications Equipment
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- VEON Telecommunications
- CNTA Health Care
- Exchange
- VEON Nasdaq
- CNTA Nasdaq
- Market Cap
- VEON 2.4B
- CNTA 2.3B
- IPO Year
- VEON 1996
- CNTA 2021
- Fundamental
- Price
- VEON $35.98
- CNTA $17.60
- Analyst Decision
- VEON Strong Buy
- CNTA Strong Buy
- Analyst Count
- VEON 1
- CNTA 7
- Target Price
- VEON $48.00
- CNTA $23.71
- AVG Volume (30 Days)
- VEON 50.0K
- CNTA 688.3K
- Earning Date
- VEON 11-14-2024
- CNTA 11-12-2024
- Dividend Yield
- VEON N/A
- CNTA N/A
- EPS Growth
- VEON N/A
- CNTA N/A
- EPS
- VEON N/A
- CNTA N/A
- Revenue
- VEON $3,955,000,000.00
- CNTA $6,853,000.00
- Revenue This Year
- VEON $12.10
- CNTA N/A
- Revenue Next Year
- VEON $7.27
- CNTA N/A
- P/E Ratio
- VEON $4.24
- CNTA N/A
- Revenue Growth
- VEON 7.36
- CNTA N/A
- 52 Week Low
- VEON $18.50
- CNTA $6.65
- 52 Week High
- VEON $38.00
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- VEON 62.48
- CNTA 54.64
- Support Level
- VEON $32.15
- CNTA $15.88
- Resistance Level
- VEON $38.00
- CNTA $17.34
- Average True Range (ATR)
- VEON 1.31
- CNTA 0.92
- MACD
- VEON 0.14
- CNTA -0.10
- Stochastic Oscillator
- VEON 65.47
- CNTA 55.66
About VEON VEON Ltd. ADS
VEON Ltd is a global provider of connectivity and internet services. The company provides its customers with voice, fixed broadband, data, and digital services. Currently, the company offers services to customers in the following countries: Pakistan, Ukraine, Kazakhstan, Bangladesh, Uzbekistan, and Kyrgyzstan. The reportable segments currently consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. The company provides services under the Beeline, Kyivstar, banglalink and Jazz brands.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.